Earnings
RARE
94.92
-1.10%
-1.06
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
713.53M
488.01M
--
23.09M
--
--
0.00
--
13.05M
--
46.78M
10.85M
1.30B
114.04M
--
165.88M
--
44.41M
131.11M
--
8.81M
464.25M
1.76B
--
12.92M
0.00
--
--
--
--
--
117.01M
--
--
--
59.22M
189.61M
701.00K
--
--
33.31M
381.56M
415.57M
605.18M
67.00K
2.77B
-1.62B
--
--
--
1.15B
1.15B
1.76B
FY 2019-12-31
433.58M
321.65M
--
32.84M
--
--
0.00
--
11.55M
--
51.24M
161.00K
851.02M
74.68M
--
32.93M
--
44.41M
129.00M
--
3.47M
284.48M
1.14B
--
12.87M
0.00
--
--
--
--
--
90.43M
--
--
--
--
103.30M
0.00
--
--
33.31M
345.13M
378.43M
481.73M
58.00K
2.09B
-1.43B
--
--
--
653.76M
653.76M
1.14B
FY 2018-12-31
113.43M
346.27M
--
12.74M
--
--
0.00
--
7.07M
--
42.59M
271.00K
522.37M
20.05M
--
0.00
--
44.41M
129.22M
--
3.51M
197.19M
719.56M
--
12.28M
0.00
--
--
--
--
--
62.45M
--
--
--
--
74.72M
0.00
--
--
31.17M
4.76M
35.92M
110.65M
51.00K
1.64B
-1.03B
--
--
--
608.91M
608.91M
719.56M
FY 2017-12-31
100.49M
134.00M
--
5.17M
--
--
0.00
--
757.00K
--
28.70M
461.00K
269.58M
21.84M
--
9.97M
--
44.41M
141.54M
--
3.41M
221.17M
490.75M
--
8.89M
0.00
--
--
--
--
--
61.43M
--
--
--
701.00K
71.01M
0.00
--
--
31.17M
5.12M
36.28M
107.30M
44.00K
1.22B
-832.67M
--
--
--
383.45M
383.45M
490.75M
FY 2016-12-31
161.12M
219.03M
--
--
--
--
0.00
--
--
--
20.14M
1.41M
401.69M
17.05M
--
117.96M
--
--
--
--
3.91M
138.93M
540.63M
--
5.36M
0.00
--
--
--
--
--
54.55M
--
--
--
341.00K
60.26M
0.00
--
--
--
6.39M
6.39M
66.65M
41.00K
1.00B
-530.53M
--
--
--
473.97M
473.97M
540.63M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out RARE latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Ultragenyx recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.